Activist Investor 13D Filings


This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

DateFormInvestorTargetSharesOwnership
(Percent)
Ownership Change
(Percent)
2018‑06‑19 SC 13D/A venBio Select Advisor LLC IMMU / Immunomedics 17,714,461 9.9 1.14
2018‑06‑19 SC 13D/A WILCOX GARY COCP / Cocrystal Pharma 10,361,985 34.48
2018‑06‑18 SC 13D Akkaraju Srinivas VSAR / Versartis, Inc.. 2,682,554 7.4
2018‑06‑18 SC 13D/A LFB Biotechnologies S.A.S.U. TGTX / TG Therapeutics 7,614,855 9.8 0.00
2018‑06‑18 SC 13D CITIC Capital Holdings Ltd CBPO / China Biologic Products 1,680,863 5.1
2018‑06‑15 SC 13D Roivant Sciences Ltd. AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑15 SC 13D/A venBio Select Advisor LLC IMMU / Immunomedics 17,514,461 9.8 3.39
2018‑06‑14 SC 13D Groman John E VNTH / Nano Mobile Healthcare 1,387,363 37.82 -93.93
2018‑06‑14 SC 13D Finnegan Cara Marie VNTH / Nano Mobile Healthcare 457,500 26.2
2018‑06‑14 SC 13D Swan Allison Carol VNTH / Nano Mobile Healthcare 13,063 9.99
2018‑06‑11 SC 13D/A SMITH CLARENCE EDWARD PKTX / ProtoKinetix 75,880,942 28.3 5.06
2018‑06‑11 SC 13D/A Healios K.k. ATHX / Athersys 16,000,000 11.3 33.33
2018‑06‑08 SC 13D/A Satter Muneer A VTL / Vital Therapies 11,597,719 27.2 5.10
2018‑06‑07 SC 13D/A Svf Investments (uk) Ltd AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A QVT Financial LP AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A Lo Andrew AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A Dexxon Holdings Ltd. AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑07 SC 13D/A Machado Patrick AXON / Axovant Sciences 89,285,714 73.1 19.05
2018‑06‑06 SC 13D Lake Shore Advisors Llc NPHC / Nutra Pharma 187,500,000 8.04
2018‑06‑05 SC 13D/A ACCESS INDUSTRIES MANAGEMENT, LLC LOXO / Loxo Oncology 857,982 2.85 -50.73
2018‑06‑05 SC 13D/A Seattle Genetics Inc /wa IMMU / Immunomedics 8,282,804 4.9 -28.94
2018‑06‑05 SC 13D/A New Enterprise Associates 12, Limited Partnership ARDX / Ardelyx 16,736,044 27.2 8.07
2018‑06‑04 SC 13D/A Invus, L.P. LXRX / Lexicon Pharmaceuticals 59,002,706 55.8
2018‑06‑01 SC 13D/A Wentz Myron W USNA / USANA Health Sciences 10,579,899 43.8 -4.04
2018‑05‑31 SC 13D/A Alta Partners VIII, L.P. AGTC / Applied Genetic Technologies 51,896 0.3 -95.46
2018‑05‑31 SC 13D/A Vatera Holdings Llc MLNT / Melinta Therapeutics 16,607,959 29.7
2018‑05‑29 SC 13D/A MacAndrews & Forbes Inc. VTVT / vTv Therapeutics 28,181,305 79.8 0.18
2018‑05‑25 SC 13D/A Invesco Ltd. EVFM / Evofem Biosciences 9,590,688 35.94
2018‑05‑24 SC 13D Schreiber Justin IMMD / ImmuDyne 7,120,329 16.15
2018‑05‑24 SC 13D/A Sofinnova Venture Partners IX, L.P. LIFE / aTyr Pharma 1,694,528 5.7 -9.25
2018‑05‑24 SC 13D/A THREE ARCH PARTNERS IV LP ACRX / AcelRx Pharmaceuticals 0 0.0 -100.00
2018‑05‑23 SC 13D Growth Equity Opportunities V, LLC MEIP / MEI Pharma 7,025,641 9.99
2018‑05‑22 SC 13D/A Starboard Value LP DEPO / DepoMed 2,703,995 4.3 -30.40
2018‑05‑22 SC 13D/A Wentz Myron W USNA / USANA Health Sciences 11,025,753 45.8 0.00
2018‑05‑21 SC 13D/A Broadfin Capital, LLC BDSI / BioDelivery Sciences International 4,278,819 7.2 0.00
2018‑05‑21 SC 13D/A Biotest Pharmaceuticals Corp ADMA / ADMA Biologics 10,109,534 27.53
2018‑05‑21 SC 13D/A Engaged Capital LLC PETX / Aratana Therapeutics 2,400,000 5.1 0.00
2018‑05‑18 SC 13D/A Bp Peptides, Llc CAPS / Capstone Therapeutics 20,488,518 36.4 4.93
2018‑05‑18 SC 13D/A BIOTIME INC AST / Asterias Biotherapeutics 13.0
2018‑05‑18 SC 13D/A Manchester Management Pr, Llc FENCF / Fennec Pharmaceuticals 1,833,332 8.9 0.00
2018‑05‑17 SC 13D Op Financial Ltd NBY / NovaBay Pharmaceuticals 1,700,000 9.9
2018‑05‑17 SC 13D/A Adage Capital Partners GP LLC AVXS / AveXis 0 0.0 -100.00
2018‑05‑17 SC 13D/A ARMISTICE CAPITAL, LLC EYEG / Eyegate Pharmaceuticals 16,742,500 40.2 3.05
2018‑05‑16 SC 13D/A Eastern Capital LTD TPIV / TapImmune 5,300,002 38.8 32.50
2018‑05‑15 SC 13D/A APPLE TREE PARTNERS II LP TKAI / Tokai Pharmaceuticals 13,888 0.1 -98.23
2018‑05‑15 SC 13D/A Lee's Pharmaceutical Holdings Ltd WINT / Windtree Therapeutics 3,122,488 78.0 -2.51
2018‑05‑14 SC 13D/A SPECTRUM PHARMACEUTICALS INC CASI / CASI Pharmaceuticals 11,547,675 13.42
2018‑05‑14 SC 13D/A Starboard Value LP DEPO / DepoMed 3,885,295 6.1 -17.95
2018‑05‑10 SC 13D/A Baupost Group LLC/MA KERX / Keryx Biopharmaceuticals 61,374,013 39.66 3.65
2018‑05‑07 SC 13D Mannello Joseph MYOS / MYOS RENS Technology 716,893 9.3